In 2020, the pandemic of COVID-19 swept the world. As a company focusing on respiratory health, BMC bears in mind its mission and is duty-bound to fight against the epidemic.
In the early stage of the outbreak, BMC immediately integrated its inventory and quickly responded to the market. In order to meet the first-line demands, BMC made every effort to increase its production capacity. BMC’s Non-invasive ventilators, HFNO (high-flow nasal cannula oxygenation) therapy devices, ventilation masks and other products have been widely used in the frontline of anti-epidemic, and the cloud based BMC+ respiratory health management platform is also free of charge for all hospitals.
Facing the increasingly turbulent international epidemic, BMC has played a huge role in the global market layout. BMC products have CE and other global registration certifications, and have obtained FDA emergency use authorization to allow them to quickly complete overseas support. At present, BMC has provided tens of thousands of ventilators, thousands of HFNO (high-flow nasal cannula oxygenation) therapy devices and hundreds of thousands ventilation masks to the world.
Facing the increasing cost of raw materials and labor, BMC maintained product price stability, strictly controlled quality, improved after-sales service network, and resolutely cracked down on illegal activities in the market to promote healthy development of the industry. So far, BMC has donated medical materials which is worth more than 5.8 million Chinese Yuan to the whole country.
The epidemic is not over yet, and prevention and control are still in progress. We are willing to take the greatest courage and responsibility to protect the human health.
Chairman of BMC Medical